Table 1.
Clinical and Molecular Characteristics of Affected and Unaffected Family Members Studied
Measurement in Right Eye, Left Eye |
|||||||
---|---|---|---|---|---|---|---|
Patient No./ Sex/Age at Visit, y |
Nucleotide Changes at c.1381, No. |
Protein Change of Q461Stop |
Visual Acuitya |
Refraction | Axial Length | Color Vision TCDS/CCI |
Desaturated Color Vision TES/CCIb |
III-1/F/64 | C/T | Heterozygous | 20/32, 20/20 | −3.00+1.00×005, plano+0.40×180 |
23.57, 23.53 | 129.2/1.10, 117/1.00 |
32/1.23, 32/1.23 |
III-2/M/73 | C/T | Heterozygous | 20/20, 20/20 | Plano, plano | NP | NP | NP |
IV-1/F/45 | T/T | Homozygous | 20/1008, 20/800 | −11.00 DS, −11.00 DS | 23.29, 23.31 | 449.5/3.84, 382.4/3.27 |
NP |
IV-2/F/37 | C/T | Heterozygous | 20/25, 20/25 | NP, NP | NP | NP | NP |
IV-3/F/36 | T/T | Homozygous | 20/160, 20/100 | −2.00+1.00×120, −2.00+1.25×085 |
23.70, 23.70 | Unable | Unable |
IV-4/F/32 | T/T | Homozygous | 20/40, 20/100 | −11.00+3.00×100, −10.50+3.00×085 |
24.73, 24.87 | 335.9/2.87, 347.6/2.97 |
NP |
IV-5/F/25 | C/T | Heterozygous | 20/20, 20/20 | Plano, plano | NP | NP | NP |
V-1/M/21 | NP | NP | 20/16, 20/16 | −0.25 DS, −0.25 DS | 23.48, 23.69 | 117/1.00, 125.4/1.10 |
48/1.34, 0/1.00 |
Abbreviations: CCI, color confusion index (calculated as the total color difference score [TCDS] of the subject divided by the normal TCDS); NP, not performed; TES, total error score.
Visual acuity represents the best spectacle-corrected acuity.
A normal TES is lower than the 95% confidence level, which is 109 for age 64 years and 51 for age 21 years.